Company
ChinaNanjing Hanxin Pharmaceutical Technology Co., Ltd., China – FDA Inspections
Inspection records and compliance data for Nanjing Hanxin Pharmaceutical Technology Co., Ltd.. 1 FDA inspection on record, 1 Form 483, last inspected March 28, 2025.
Company Profile
This profile covers Nanjing Hanxin Pharmaceutical Technology Co., Ltd. based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected March 28, 2025.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 28, 2025 | Not classified | Human Drugs | 1269301 |
FDA documents
Form 483s (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Qilu Pharmaceutical Co., Ltd. (Dongjia Site)
Emcure Pharmaceuticals Limited
SHINE Technologies, LLC
Shandong Anshun Pharmaceutical Co., Ltd.
Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd
Biovectra Inc.
MacroGenics, Inc
Patheon Biologics LLC
Apitoria Pharma Private Limited
Evive Biopharmaceutical (Beijing), Ltd.
Company Information
Name
Nanjing Hanxin Pharmaceutical Technology Co., Ltd.
FEI Number
3015142388
Address
China
Country
China
ID: 13c8b77b-dfa8-4a49-9362-09743614e722